Cogent Biosciences, Inc. (COGT)
35.24
-3.25
(-8.44%)
USD |
NASDAQ |
Apr 01, 16:00
35.24
0.00 (0.00%)
After-Hours: 20:00
Cogent Biosciences Research and Development Expense (TTM) : 265.16M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Syndax Pharmaceuticals, Inc. | 258.78M |
| Vera Therapeutics, Inc. | 214.79M |
| Terns Pharmaceuticals, Inc. | 77.89M |
| Nuvalent, Inc. | 306.97M |
| Insmed, Inc. | 771.09M |